Safety and immunogenicity of a synthetic nanoparticle-based, T cell priming peptide vaccine against dengue in healthy adults in Switzerland: a double-blind, randomized, vehicle-controlled, phase 1 study-Reference-Cited by-同舟云学术

Safety and immunogenicity of a synthetic nanoparticle-based, T cell priming peptide vaccine against dengue in healthy adults in Switzerland: a double-blind, randomized, vehicle-controlled, phase 1 study

Published:2024-01 Issue: Volume:99 Page:104922
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Miauton Alix^ORCID,Audran Régine,Besson Juliette,Maby-El Hajjami Hélène,Karlen Maxime,Warpelin-Decrausaz Loane,Sene Loredana,Schaufelberger Sylvain,Faivre Vincent,Faouzi Mohamed,Hartley Mary-Anne,Spertini François,Genton Blaise

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference36 articles.

1. The global distribution and burden of dengue;Bhatt;Nature,2013

2. Fact sheets: dengue and severe dengue,2017

3. Global expansion and redistribution of Aedes-borne virus transmission risk with climate change;Ryan;PLoS Negl Trop Dis,2019

4. Global, regional, and national dengue burden from 1990 to 2017: a systematic analysis based on the global burden of disease study 2017;Zeng;EClinicalMedicine,2021

5. Ten threats to Global Health in 2019,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in clinical application of nanoparticle-based therapy for cancer treatment: A systematic review;Nano TransMed;2024-12

2. Eosinophils as modulators of host defense during parasitic, fungal, bacterial, and viral infections;Journal of Leukocyte Biology;2024-08-13

3. Next-generation Dengue Vaccines: Leveraging Peptide-Based Immunogens and Advanced Nanoparticles as Delivery Platforms;Journal of Pharmaceutical Sciences;2024-08

4. Exploring the Modern Bioactive Peptides (BAPs) Universe: Doors to the Future;Peptide Science;2024-06-15

5. The immunostimulatory roles of gold nanoparticles in immunization and vaccination against Brucella abortus antigens;International Immunopharmacology;2024-05